Acurx Pharmaceuticals, Inc. Stock Redeemed or Called During Period, Value
Acurx Pharmaceuticals, Inc. (ACXP) reported Stock Redeemed or Called During Period, Value of $1.04 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Shareholders' Equity
us-gaap:StockRedeemedOrCalledDuringPeriodValue · last filed 2026-03-12
- Acurx Pharmaceuticals, Inc. stock redeemed or called during period, value for the quarter ending 2025-09-30 was $1.04K.
- Acurx Pharmaceuticals, Inc. stock redeemed or called during period, value for fiscal 2025 was $1.04K.
| Period end | Stock Redeemed or Called During Period, Value 3 month | Stock Redeemed or Called During Period, Value 12 month |
|---|---|---|
| 2025-12-31 | $1.04K 10-K · filed 2026-03-12 | |
| 2025-09-30 | $1.04K 10-Q · filed 2025-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B |